These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10792300)
1. Effects of intravenous immunoglobulin in a patient with intermittent thrombotic thrombocytopenic purpura. Kondo H; Imamura T Br J Haematol; 2000 Mar; 108(4):880-2. PubMed ID: 10792300 [TBL] [Abstract][Full Text] [Related]
2. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Moake JL; McPherson PD Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537 [TBL] [Abstract][Full Text] [Related]
3. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission. Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507 [TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers. Rowe JM; Francis CW; Cyran EM; Marder VJ Am J Hematol; 1985 Oct; 20(2):161-8. PubMed ID: 3876029 [TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura. Moake JL; Rudy CK; Troll JH; Weinstein MJ; Colannino NM; Hong SL; Koutcher JA; Melaragno AJ; Manner CE Am J Med Sci; 1986 Jan; 291(1):47-50. PubMed ID: 3079954 [TBL] [Abstract][Full Text] [Related]
6. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. Chintagumpala MM; Hurwitz RL; Moake JL; Mahoney DH; Steuber CP J Pediatr; 1992 Jan; 120(1):49-53. PubMed ID: 1731024 [TBL] [Abstract][Full Text] [Related]
7. Long-lasting remission after high-dose intravenous immunoglobulins in a case of relapsing thrombotic thrombocytopenic purpura. Castaman G; Rodeghiero F; Ruggeri M; di Bona E; Dini E Haematologica; 1991; 76(6):511-2. PubMed ID: 1820990 [TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura. Moake JL Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504 [TBL] [Abstract][Full Text] [Related]
9. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
10. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285 [TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura. Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362 [TBL] [Abstract][Full Text] [Related]